The Light Festival in Zagreb will attract over 100.000 visitors

first_imgArt, design, spectacle, entertainment, architecture, it’s all a Festival of Light. From March 15 to 18, the Zagreb Light Festival will be held for the second time in the Croatian capital, uniting the most modern lighting solutions based on lighting technologies in the historic core.The theme of the festival is spring, which symbolizes awakening, growth and renaissance, so each of the locations will in its own way evoke a spring atmosphere through light performances that will take place from 18 to 23 hours. The first Festival of Light Zagreb was held last year at seven locations, and attracted almost 100.000 visitors, while this year the Tourist Board expects it to exceed that magic number. This year, the festival has expanded significantly and from the initial seven locations has grown to as many as 19 locations in the city: in the Grič tunnel, Art Park, Tomićeva Street, Lotrščak Tower, near the monument to AG Matoš, Vranicanijeva poljana, Grič Park, Gradec plateau, in the atrium and Klovićevi dvori Gallery, Jesuit Square, Opatička Street, Croatian Institute of History, large courtyard and northern courtyard of the Zagreb City Museum, Vrazov šetalište, children’s playground on Dubravkin put, Tuškanac summer stage and Tuškanac.In the meantime, there is no need to worry about it. ”With the four-day festival, Zagreb joins other world cities, such as Lyon, Amsterdam, Helsinki, Prague, St. Petersburg or Berlin, which havetradition of holding such festivals, and the Festival of Lights in Zagreb was included in the international organization Festival of Lights International last year. The festival of good emotions and beautiful scenes where light artists use the city and its views as a painting canvas announces the tourist season, and through innovative art and the magic of light creates another reason to visit the Croatian capital.The Zagreb Festival of Light is an event that announces the tourist season and invites you to enjoy the outdoors in the spring evenings through an innovative way. I always emphasize that the motive for coming is a diverse, high-quality and authentic experience, and the Festival of Light is certainly a different and quality content, and thus the motive for coming to Zagreb. Admission to all programs is free, and more information is available at: read more

Gilead in talks to expand global supply of COVID-19 drug remdesivir

first_imgGilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.The drugmaker did not disclose details about the companies.With several countries across the globe reeling from the virus outbreak, interest in remdesivir has been high as there are currently no approved treatments or vaccines for COVID-19, the respiratory illness caused by the new coronavirus. Gilead last week received the US Food and Drug Administration’s emergency use authorization for using remdesivir as a treatment against COVID-19, after the drugmaker provided data showing the drug had helped COVID-19 patients.Gilead also said on Tuesday it was negotiating long-term licenses with several generic drugmakers in India and Pakistan to produce remdesivir for developing countries and that it would provide technology to aid the production.One of Bangladesh’s largest drugmakers, Beximco Pharmaceuticals, will start remdesivir production this month, Reuters reported on Tuesday, citing a senior company executive.Remdesivir was previously available only for patients enrolled in clinical trials or those cleared to get the drug under expanded use and compassionate use programs.Gilead, which has already said it will donate the first 1.5 million doses of remdesivir, also previously said it was focused on making the drug accessible and affordable to as many people as possible upon approval.Gilead said it was working to build a consortium of manufacturing partners to help maximize global supply of the drug, which requires scarce raw materials and specialized manufacturing capabilities with limited global capacity.The company also said it was in advanced talks with UNICEF to deliver remdesivir using the agency’s distribution networks. Topics :last_img read more

La Liga Watch: Top Two Maintain Unbeaten Status With Stalemate As Sevilla Show Power…

first_imgValencia and Barcelona have maintained their unbeaten start to the league season after the top two La Liga teams played out an entertaining 1-1 draw at the Mestalla.In-form Spanish striker Rodrigo gave the home side the lead on the hour mark but Los Che could not hold on for what would have been a massive win as Barcelona fought back eight minutes from time through left back Jordi Alba for a share of the spoils.Sevilla showed their power of recovery again on Sunday evening after coming from two goals down to win 3-2 at 10-man Villareal.Eduardo Berizzo’s men had earlier recovered from a 3-0 deficit to play a 3-3 draw against Liverpool in their UEFA Champions League (UCL) clash on Tuesday night and they showed that again in the league.Clement Lenglet and Franco Vazquez scored two goals within one second half minute to pull Sevilla level at 2-2 after Cedric Bakambu and Carlos Bacca had given Villareal a 2-0 lead.Sevilla however went on to snatch the points 12 minutes from time courtesy Ever Banega’s penalty after Villareal defender Victor Ruiz was penalised and subsequently sent off for two yellow cards.Week 13 Results (Sunday)Villareal 2-3 SevillaValencia 1-1 BarcelonaDeportivo La Coruna 2-2 Athletic BilbaoReal Sociedad 2-2 Las PalmasTop 4 (Standings):1. Barcelona 35 points2. Valencia 31 points3. Atletico Madrid 27 points4. Real Madrid 27 pointsRelatedLa Liga Review: Atletico Capitalise On Barcelona To Narrow Gap With Valencia WinFebruary 5, 2018In “Europe”Spanish La Liga Wrap (Saturday): Top Two Secure Wins As Atletico Falter AgainOctober 29, 2017In “Europe”La Liga Review: Atletico Thrash Sevilla To Trim Gap On Leaders BarcelonaFebruary 26, 2018In “Europe”last_img read more